Clinical reference
Antibiotic · Macrolide (minimally absorbable, gut-selective) · Infectious Diseases, Gastroenterology, Pediatrics, Internal Medicine
Fidaxomicin is an oral macrolide-class antibiotic with minimal systemic absorption and bactericidal activity against Clostridioides (Clostridium) difficile. It is used for treatment of C. difficile infection (CDI). Oral suspension: 40 mg/mL (136 mL), contains sodium benzoate. Tablets: 200 mg, contain soybean lecithin.